Prelude Fertility
Franklin
About Prelude Fertility
Prelude Fertility is a reproductive health and technology company with a network of fertility clinics throughout the United States. Prelude mission is to educate women and men about their reproductive health and provide them with the best options, science, and care so they have the opportunity to become a parent when they are ready. Martin Varsavsky came up with the idea for Prelude Fertility in 2015 and the following year obtained funding from Lee Equity Partners to begin the business. Prelude Fertility began with the acquisition of Reproductive Biology Associates of Atlanta and its sister company, My Egg Bank North America, in 2016. Since then, the Prelude Network has expanded to include dozens of clinics across the United States. In October 2018, Prelude partnered with NYU’s Langone Health to expand its fertility services. In March 2019, the Prelude Network partnered with Inception Fertility to create the largest network of fertility clinics in the United States. Prelude Fertility prides itself on enhancing fertility technology and extending the timeframe in which women can have healthy babies. Home to the largest egg donor bank in North America, Prelude offers clients access to more donor eggs than any other clinic in America. Prelude was founded on the idea that clients shouldn’t have to work with multiple companies to achieve their reproductive goals. Prelude’s services include IVF, embryo creation and transfer, egg freezing, egg storage, genetic testing and egg donation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $200.0M
- Funding stage: Private Equity
- Last round: Private Equity (Aug 2017)
- Website: preludefertility.com
- Phone: (877) 959-3704
Industries & Categories
Fertility, Genetics, Health Care, Hospitality, Women's
Social Profiles
Canonical: https://fsome.com/organization/prelude-fertility-63286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.